Literature DB >> 15016319

Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients.

Kazuya Yamashita1, Shuichi Yasuda, Tatsuru Kuba, Yoshimasa Otani, Mutsunori Fujiwara, Isao Okayasu.   

Abstract

To identify the characteristics of ulcerative colitis (UC)-associated carcinomas, 8 lesions, high-grade dysplasias and invasive carcinomas, were implanted into severely combined immunodeficient (SCID) mice and/or cultured in vitro. Intramucosal neoplasias consisting of high-grade dysplasia showed extremely slow proliferation after implantation (2/3 cases) and in vitro culture failed (4 cases). However, invasive carcinomas demonstrated rapid growth both after SCID mouse implantation and in vitro (4/4 cases). From two cases of invasive carcinomas, 6 cell lines were established, and these are the first to be described in the literature. In addition to variation in immunohistochemically determined phenotypic expression regarding alpha-fetoprotein, chromogranin A and estrogen receptors, the established cell lines showed varying differentiation (moderately or poorly differentiated adenocarcinoma, adenosquamous carcinoma and poorly differentiated adenocarcinoma with multinuclear giant cells and bone formation). The results are in contrast with findings for sporadic colorectal carcinomas. Although the prevalence of DNA alterations is not frequent, loss of heterozygosity (17p and 18q) and deletion of exons 8 to 11 in DPC-4 were revealed in all of 6 cell lines, suggesting relatively high genetic instability. We found loss or translocation of many chromosomes (#3, 5, 6, 8, 10, 11, 13, 16, 17, 18 and 19) other than chromosomes 1, 5, 8, 11, 13, 17 and 18, which are frequently involved in sporadic colorectal carcinoma cell lines. Thus, the established cell lines may be good models of tumorigenesis and progression in the chronic inflammation-carcinoma sequence.

Entities:  

Mesh:

Year:  2004        PMID: 15016319     DOI: 10.1111/j.1349-7006.2004.tb02205.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  4 in total

1.  CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid.

Authors:  Tsutomu Yoshida; Tsukasa Sekine; Ken-ichi Aisaki; Tetuo Mikami; Jun Kanno; Isao Okayasu
Journal:  J Gastroenterol       Date:  2010-12-17       Impact factor: 7.527

2.  Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms.

Authors:  Natsuko Tatsumi; Ryoji Kushima; Michael Vieth; Ken-Ichi Mukaisho; Rie Kakinoki; Hidetoshi Okabe; Franz Borchard; Manfred Stolte; Takeshi Okanoue; Takanori Hattori
Journal:  Virchows Arch       Date:  2006-04-12       Impact factor: 4.064

3.  Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry.

Authors:  Kayo Horie; Tetuo Mikami; Tsutomu Yoshida; Yuichi Sato; Isao Okayasu
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach.

Authors:  K Araki; T Mikami; T Yoshida; M Kikuchi; Y Sato; M Oh-ishi; Y Kodera; T Maeda; I Okayasu
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.